Filter
260
Filtered Results: 260
Text search:
Guillain-Barrè
Syndrome
Featured
Recommendations
32
New Publications
139
Language
Document type
No document type
186
Guidelines
39
Studies & Reports
10
Manuals
9
Fact sheets
6
Strategic & Response Plan
4
Training Material
3
Situation Updates
2
Resource Platforms
1
Countries / Regions
Brazil
19
Latin America and the Carribbean
10
India
9
Argentina
7
Philippines
5
Western and Central Europe
5
Colombia
4
Venezuela
4
Germany
4
Paraguay
4
Africa
3
Bangladesh
3
Namibia
3
Nigeria
2
Zimbabwe
2
Global
2
Dominican Republic
2
South Africa
2
Nepal
1
Kenya
1
Rwanda
1
Senegal
1
Mozambique
1
Italy
1
USA
1
Haiti
1
Cape Verde
1
Portugal
1
Bolivia
1
Russia
1
Honduras
1
Angola
1
Indonesia
1
Liberia
1
Ecuador
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Guidelines
30
COVID-19
20
Policies & Guidelines HIV & TB
11
Studies & Reports
6
Vector Control
5
Vaccine-preventable Diseases
5
Paediatrics
4
NTDs & Others
4
Yellow Fever
3
Women & Child Health
3
Community Health
3
Clinical Guidelines
2
Policies
2
Drugs & Medical Equipment
2
Information, Education and Communication (IEC)
2
Disease Prevention & Control
2
Communicable Diseases
1
Zika
1
Dental & Eye Care
1
Rabies
1
Pharmacy & Technology
1
Under-5 nutrition
1
Dermatology
1
Snakebites
1
Pediatrics
1
Capacity Building
1
Humanitarian Crisis
1
Mental Health
1
Diarrhoea
1
Respiratory Infections
1
General Guidelines
1
Communicable Diseases
1
Gynaecology & Obstetrics
1
Maternal Health
1
Dengue
1
Leishmaniasis
1
Non-communicable Diseases
1
HIV & STI
1
Toolboxes
Context & Facts
28
Gynaecology / Obstetrics
19
Risk Communication & Community Engagement
16
Preparedness & Prevention
14
Country specific documents
12
Zika Prevention & Control
12
Clinical Guidelines
10
Situation Reports
10
Microcephaly
8
Travel Medicine
8
Health Systems
7
National Emergency Response Plans
7
Travel Advice
6
Long COVID/ Post-COVID Syndrome
6
Guillain-Barré Syndrome
5
For General Public
5
Vector Control
5
Paediatrics
5
Case Definitions
5
Public Health
4
Surveillance
4
Clinical Guidelines
4
Vector control
4
General Information Material
4
Chikungunya Prevention & Control
4
Pregnant women
4
Yellow Fever
3
Public Health
3
Psychosocial Support
3
Immunization Guidelines
3
Vaxzevria (Astra Zeneca)
3
Laboratory & Diagnostics
3
Surveillance
2
Clinical Aspects
2
Vaccination
2
Climate & Health
2
Global Impact: Socio-economic, health services, TB & HIV
2
Communication Material
2
Others
2
Health Impact & Climate Change
2
Global Overview
2
Neurological Disorders
2
Meningitis & Encephalitis
2
Africa
1
ART Drug Resistance
1
Children & Adolescents
1
Dengue
1
Treatment Guidelines HIV
1
General Studies & Reports
1
Research
1
Communication
1
Context & Facts, Travel Advice
1
COVID-19
1
Surveillance & Contact tracing
1
For Pregnant Women
1
Scientific & Research Studies
1
Gender Aspects
1
Paediatrics
1
General
1
MHPSS – Psychosocial Support
1
Access & Strategy
1
COVID-19 Vaccination
1
Logistics & Supply
1
COVID-19 Vaccination Information
1
Vaccine Hesitancy & Myths
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Vector-based Vacines General
1
Johnson & Johnson
1
Inactivated COVID-19 Vaccines
1
Others
1
Nurses
1
Booster Doses
1
Essential Medicines & Devices Lists
1
Rational use of Medicine
1
Resuscitation
1
Pharmacovigilance
1
Information Refugees Ukraine
1
COVID-19
1
Education material
1
Leishmaniasis
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Information & Education Material (IEC)
1
NTDs General
1
Overview, Studies & Reports
1
Snakebite envenoming
1
Studies & Reports
1
Co-Morbidities (except TB)
1
Zika
1
General Aspects
1
Education of students & professionals
1
Germany
1
Dengue Prevention & Control
1
HIV and coinfection
1
Others
1
Antiretroviral Treatment ART
1
Chikungunya
1
Assecced: 03.09.2019
Este documento apresenta orientações provisórias para uma comunicação eficaz dos riscos relacionados com atransmissão do vírus Zikae das suas potenciais complicações. Ainda não foi, contudo, estabelecida uma relação causal entre ainfecçãopelo vírus Zika e essas potenciais complicaçõ...
Se espera que sean una referencia para la elaboración de protocolos clínicos y políticas sanitarias a nivel nacional y local relacionados con el embarazo, en el contexto de la transmisión del virus de Zika, pero no se pretende ofrecer una guía práctica completa para la prevención y el tratami...
Lignes directrices provisoires actualisées 7 juin 2016
Le présent document donne des lignes directrices provisoires afin de garantir l’efficacité des communications sur les risques relatives à la transmission du virus Zika et aux complications potentielles. Le lien de causalité entre l’infection à virus Zika et ces complications potentielles n...
Standard Treatment Guideline
Management of Snake Bite. Quick Reference Guide
recommended
Standard Treatment Guideline
Accessed Febr. 6, 2020
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
